Indaptus Therapeutics Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Indaptus Therapeutics Inc.
Former names: Intec Parent Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: New York
Headquarters state / province: New York
Headquarters country: United States
Fiscal year end: December
Ticker symbol: INDP
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001857044
EIN: 86-3158720

Board of directors

Follow this board

Anthony J. Maddaluna · Director
Since 2023
Avraham Ben-Tzvi · Director Overboarded
Since 2025
David E. Lazar · Director Overboarded
Since 2026
David Natan · Director Overboarded
Since 2026
Hila Karah · Director
Since 2023
Jeffrey A. Meckler · Director · Co-Chief Executive Officer
Since 2023
Jerome D. Jabbour · Director
Since 2026
Mark John Gilbert · Director
Since 2023
Matthew Charles McMurdo · Director
Since 2026
Michael James Newman · Director · CSO and Director
Since 2023
Qinglai Lu · Director
Since 2026
Robert Martell · Director
Since 2023
Roger Pomerantz · Director
Since 2023
William B. Hayes · Director
Since 2023

Chief executives

Jeffrey A. Meckler · CEO and Director

Dates unknown

Director election results

Annual meeting of August 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

David Natan

100.0%

Board connections

9 of this board's directors also sit on 16 other boards. 7 are in the same sector.

Shared director Other board Same sector

FiEE Inc
via Avraham Ben-Tzvi, David E. Lazar, David Natan and Matthew Charles McMurdo
Aterian Inc.
via Avraham Ben-Tzvi, David E. Lazar and David Natan
Bio Green Med Solution Inc.
via Avraham Ben-Tzvi, David E. Lazar and David Natan
Quantum Cyber N.V. Same sector
via Avraham Ben-Tzvi, David E. Lazar and David Natan
LQR House Inc.
via Avraham Ben-Tzvi and David E. Lazar
Sow Good Inc.
via David E. Lazar and David Natan
Black Titan Corporation
via Avraham Ben-Tzvi
Builders FirstSource Inc.
via William B. Hayes
DarioHealth Corp. Same sector
via Hila Karah
Enlivex Ltd. Same sector
via Roger Pomerantz
Highway Holdings Limited
via David E. Lazar
KALA BIO Inc. Same sector
via David E. Lazar
Matinas Biopharma Holdings Inc. Same sector
via Jerome D. Jabbour
Stablecoin Development Corporation
via David E. Lazar
Sunshine Biopharma Inc. Same sector
via David Natan
Travere Therapeutics Inc. Same sector
via Jeffrey A. Meckler

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Jan 20, 2026	Avraham Ben-Tzvi Director	Grant or award	+25,000	—	—
Dec 22, 2025	Sassi Nir Officer (Chief Financial Officer)	Grant or award	+26,758	$2.03	$54,319
Dec 22, 2025	Jeffrey A. Meckler Director, Officer (Co-Chief Executive Officer), 10% owner	Grant or award	+216,617	$2.03	$439,733
Dec 22, 2025	Linscott Walt Addison Officer (Chief Operating Officer)	Grant or award	+54,421	$2.03	$110,475
Dec 22, 2025	Michael James Newman Director, Officer (CSO and Director)	Grant or award	+52,204	$2.03	$105,974
Jul 27, 2025	Jeffrey A. Meckler Director, Officer (Chief Executive Officer)	Grant or award	+6,068	$8.30	$50,364
Nov 25, 2024	Jeffrey A. Meckler Director, Officer (CEO and Director)	Grant or award	+42,553	$1.18	$50,213
Aug 8, 2024	Jeffrey A. Meckler Director, Officer (CEO and Director)	Grant or award	+84,932	$1.83	$155,426
Aug 14, 2023	Anderson Glen R. 10% owner	Open-market purchase	+23,934	$2.34	$56,006
Aug 11, 2023	Anderson Glen R. 10% owner	Open-market purchase	+35,064	$2.12	$74,336
Aug 10, 2023	Anderson Glen R. 10% owner	Open-market purchase	+44,354	$1.94	$86,047

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Indaptus Therapeutics Inc.

Who is the CEO of Indaptus Therapeutics Inc.?

Jeffrey A. Meckler is Indaptus Therapeutics Inc.'s CEO and Director.

How many directors are on Indaptus Therapeutics Inc.'s board?

Indaptus Therapeutics Inc.'s board has 14 directors: Anthony J. Maddaluna, Avraham Ben-Tzvi, David E. Lazar, David Natan, Hila Karah, Jeffrey A. Meckler, Jerome D. Jabbour, Mark John Gilbert, Matthew Charles McMurdo, Michael James Newman and 4 others.

How is Indaptus Therapeutics Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="indaptus-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.